Romin Pajouheshnia
Overview
Explore the profile of Romin Pajouheshnia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pajouheshnia R, Gini R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5871.
PMID: 39145406
Purpose: Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency-funded project (EUPAS39322), defined a set of metadata to describe real-world data sources (RWDSs) and...
2.
Gini R, Pajouheshnia R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5884.
PMID: 39145403
No abstract available.
3.
Gini R, Pajouheshnia R, Gardarsdottir H, Bennett D, Li L, Gulea C, et al.
Pharmacoepidemiol Drug Saf
. 2024 May;
33(5):e5787.
PMID: 38724471
Purpose: Real-world evidence (RWE) is increasingly used for medical regulatory decisions, yet concerns persist regarding its reproducibility and hence validity. This study addresses reproducibility challenges associated with diversity across real-world...
4.
Prosepe I, Groenwold R, Knevel R, Pajouheshnia R, van Geloven N
Front Epidemiol
. 2024 Mar;
2:899589.
PMID: 38455309
Background: The SARS-CoV-2 pandemic has boosted the appearance of clinical predictions models in medical literature. Many of these models aim to provide guidance for decision making on treatment initiation. Special...
5.
Duran C, Riera-Arnau J, Abtahi S, Pajouheshnia R, Hoxhaj V, Gamba M, et al.
Front Pharmacol
. 2023 Sep;
14:1207976.
PMID: 37663263
In March 2018, the European pregnancy prevention programme for oral retinoids was updated as part of risk minimisation measures (RMM), emphasising their contraindication in pregnant women. To measure the impact...
6.
Abtahi S, Pajouheshnia R, Duran C, Riera-Arnau J, Gamba M, Alsina E, et al.
Drug Saf
. 2023 Jun;
46(7):689-702.
PMID: 37294532
Introduction: Due to established teratogenicity of valproates, the EU risk minimisation measures (RMMs) with a pregnancy prevention programme (PPP) for valproate were updated in March 2018. Objectives: To investigate the...
7.
Hageman S, Petitjaen C, Pennells L, Kaptoge S, Pajouheshnia R, Tillmann T, et al.
Eur J Prev Cardiol
. 2023 Jun;
30(15):1705-1714.
PMID: 37264679
Aims: In clinical practice, factors associated with cardiovascular disease (CVD) like albuminuria, education level, or coronary artery calcium (CAC) are often known, but not incorporated in cardiovascular risk prediction models....
8.
Hunt N, Pajouheshnia R, Salih A, van Doorn S, Souverein P, Bazelier M, et al.
Br J Clin Pharmacol
. 2023 Mar;
89(7):2263-2271.
PMID: 36890111
Aims: Low-dose rivaroxaban has been indicated for the management of atherosclerotic cardiovascular disease (ASCVD) after recent (2019-2020) updates to European guidelines. We aimed to describe prescription trends of low-dose rivaroxaban...
9.
van den Dries C, Pajouheshnia R, van den Ham H, Souverein P, Moons K, Hoes A, et al.
Br J Clin Pharmacol
. 2022 Sep;
89(2):751-761.
PMID: 36102068
Aim: To investigate the effects of off-label non-vitamin K oral anticoagulant (NOAC) dose reduction compared with on-label standard dosing in atrial fibrillation (AF) patients in routine care. Methods: Population-based cohort...
10.
Leung M, Bazelier M, Souverein P, Uitdehaag B, Klungel O, Leufkens H, et al.
Mult Scler
. 2022 May;
28(11):1808-1818.
PMID: 35575214
Background: People with multiple sclerosis (pwMS) have an increased risk of infections; risk factors include underlying disease, physical impairment and use of some disease-modifying treatments. Objective: To quantify changes in...